000 01560cam  2200337zi 4500
0019.894460
003CaOODSP
00520221107173737
006m     o  d f      
007cr cn|||||||||
008201208s2020    onca    o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-133/30-2020E-PDF
24500|aCOVID-19 antibody (serology) testing : |binformation for patients.
264 1|a[Ottawa] : |bGovernment of Canada = Gouvernement du Canada, |c2020.
300 |a1 online resource (2 unnumbered pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: À propos de la détection des anticorps contre la COVID-19 (dépistage sérologique) : information à l’intention des patients.
500 |a"2020-11-24."
500 |aTitle from caption.
500 |aAlso issued in HTML format.
650 0|aCOVID-19 (Disease)|xDiagnosis|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tÀ propos de la détection des anticorps contre la COVID-19 (dépistage sérologique) : |w(CaOODSP)9.894462
85640|qPDF|s523 KB|uhttps://publications.gc.ca/collections/collection_2020/aspc-phac/hp5-133/HP5-133-30-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing/serological/information-for-patients.html